BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 31173295)

  • 41. lncRNA FLVCR1-AS1 silencing inhibits lung cancer cell proliferation, migration, and invasion by inhibiting the activity of the Wnt/β-catenin signaling pathway.
    Lin H; Shangguan Z; Zhu M; Bao L; Zhang Q; Pan S
    J Cell Biochem; 2019 Jun; 120(6):10625-10632. PubMed ID: 30697812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
    Sun WM; Tao W; Li JC; Zhu DM; Miao Y
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.
    Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X
    Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
    Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A tRNA fragment, 5'-tiRNA
    Mo D; Jiang P; Yang Y; Mao X; Tan X; Tang X; Wei D; Li B; Wang X; Tang L; Yan F
    Cancer Lett; 2019 Aug; 457():60-73. PubMed ID: 31078732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RTKN2 knockdown alleviates the malignancy of breast cancer cells by regulating the Wnt/β-catenin pathway.
    Zhang X; Wang J; Li H
    Sci Rep; 2023 Dec; 13(1):23023. PubMed ID: 38155217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LncRNA SNHG12 promotes proliferation and migration of hepatic progenitor cells via the Wnt/β-catenin pathway.
    Liu P; Wang J; Du W; Chen L
    Adv Clin Exp Med; 2023 Sep; 32(9):1017-1027. PubMed ID: 36994689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway.
    Guo C; Wang X; Chen LP; Li M; Li M; Hu YH; Ding WH; Wang X
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3703-3712. PubMed ID: 29949143
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long non-coding RNA ZFAS1 promotes nasopharyngeal carcinoma through activation of Wnt/β-catenin pathway.
    Chen X; Li J; Li CL; Lu X
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3423-3429. PubMed ID: 29917194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR.
    Jiang B; Zhu H; Tang L; Gao T; Zhou Y; Gong F; Tan Y; Xie L; Wu X; Li Y
    Anticancer Agents Med Chem; 2022; 22(9):1723-1734. PubMed ID: 33845750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
    Tong S; Wang X; Guo X; Lu Z
    J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LncRNA HCG18 contributes to nasopharyngeal carcinoma development by modulating miR-140/CCND1 and Hedgehog signaling pathway.
    Li L; Ma TT; Ma YH; Jiang YF
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10387-10399. PubMed ID: 31841193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long intergenic noncoding RNA LINC01287 drives the progression of cervical cancer via regulating miR-513a-5p/SERP1.
    Hu Y; Zhang W; Liu Z; Xing Q; Liu R; Yan Q; Li W; Liu X
    Hum Cell; 2022 Sep; 35(5):1577-1590. PubMed ID: 35895184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
    Xu JH; Wang Y; Xu D
    Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. lncRNA SNHG11 promotes lung cancer cell proliferation and migration via activation of Wnt/β-catenin signaling pathway.
    Liu S; Yang N; Wang L; Wei B; Chen J; Gao Y
    J Cell Physiol; 2020 Oct; 235(10):7541-7553. PubMed ID: 32239719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long non-coding RNA LINC01503 predicts worse prognosis in glioma and promotes tumorigenesis and progression through activation of Wnt/β-catenin signaling.
    Wang H; Sheng ZG; Dai LZ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1600-1609. PubMed ID: 30840283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
    Wang FH; Ma XJ; Xu D; Luo J
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long non-coding RNA human leucocyte antigen complex group-18 HCG18 (HCG18) promoted cell proliferation and migration in head and neck squamous cell carcinoma through cyclin D1-WNT pathway.
    Mao B; Wang F; Zhang J; Li Q; Ying K
    Bioengineered; 2022 Apr; 13(4):9425-9434. PubMed ID: 35389764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
    Chen H; Wang Y; Xue F
    Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.